Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Find out more about us
11 July 2018
15 June 2018
31 May 2018
10 May 2018
Find out more
Sareum actively seeks collaboration partners for its research programmes.
Sareum has an innovative pipeline of drug development candidates.
Proactive Investors, March 2018 (Video)
Share price data
Regulatory News Service (RNS)
Sareum LimitedUnit 2A, Langford ArchLondon Road, PampisfordCambridge CB22 3FXUnited Kingdom
tel: +44 (0) 1223 497700fax: +44 (0) 1223 497701
Half Year Results 2018 (0.9 MB)
Annual report PDF 2017 (2.3MB)